Write in a clean editor, then format for British Journal of Clinical Pharmacology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
British Journal of Clinical Pharmacology is a peer-reviewed journal published by Wiley, covering Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Pharmaceutical Practices and Patient Outcomes.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." British Journal of Clinical Pharmacology 12 (3): 45–58.
Formats any DOI in British Journal of Clinical Pharmacology style. No sign-up. |
| Publishes research in | Pharmacogenetics and Drug Metabolism Pharmaceutical studies and practices Pharmaceutical Practices and Patient Outcomes Pharmacological Effects and Toxicity Studies Antibiotics Pharmacokinetics and Efficacy |
| ISSN | 0306-5251 |
| Citation impact (2-yr) | 2.2 |
| h-index | 221 |
| i10-index | 9,604 |
| Total citations | 501,344 |
| Article processing charge | $4,330 |
| Top institutions publishing here | Inserm |
| Journal website | bpspubs.onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Interest in patient adherence has increased in recent years, with a growing literature that shows the pervasiveness of poor adherence to appropriately prescribed medications. However, four decades of adherence research has not resulted in uniformity in the terminology used to describe deviations from prescribed therapies. The aim of this review was to propose a new…
Advancing age is characterized by impairment in the function of the many regulatory processes that provide functional integration between cells and organs. Therefore, there may be a failure to maintain homeostasis under conditions of physiological stress. The reduced homeostatic ability affects different regulatory systems in different subjects, thus explaining at least partly the increased interindividual…
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are n-3 fatty acids found in oily fish and fish oil supplements. These fatty acids are able to inhibit partly a number of aspects of inflammation including leucocyte chemotaxis, adhesion molecule expression and leucocyte-endothelial adhesive interactions, production of eicosanoids like prostaglandins and leukotrienes from the n-6 fatty acid…
As the end organ for the treatment of local diseases or as the route of administration for systemic therapies, the lung is a very attractive target for drug delivery. It provides direct access to disease in the treatment of respiratory diseases, while providing an enormous surface area and a relatively low enzymatic, controlled environment for…
